Stryker Corporation SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results